Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pathology · Idiopathic Granulomatous Mastitis

Understanding Your Diagnosis: Idiopathic Granulomatous Mastitis (IGM)

At a Glance

Idiopathic Granulomatous Mastitis (IGM) is a rare, benign, and treatable inflammatory breast condition that frequently mimics breast cancer. It primarily affects women after pregnancy and is diagnosed via biopsy. IGM does not turn into cancer and often resolves on its own or with medication.

If you have been told you have Idiopathic Granulomatous Mastitis (IGM), you may be feeling a whirlwind of emotions. This is a rare, benign (non-cancerous), chronic inflammatory disease of the breast [1][2]. For many, the journey to this diagnosis starts with a terrifying discovery—a hard lump or a painful mass—that looks and feels exactly like breast cancer [3][4].

Why It Mimics Cancer

One of the most distressing aspects of IGM is that it is a master of disguise. On mammograms and ultrasounds, it frequently presents with features that doctors typically associate with malignancy (cancer), such as irregular shapes or increased blood flow [4][3]. On an MRI, it can show patterns like “clustered ring-like enhancement” that are also common in breast cancer [5]. Because of this “overlap,” a core needle biopsy (taking a small tissue sample) is the only way to definitely rule out cancer and confirm it is IGM [4][6].

Understanding the “Typical” Patient

While IGM can affect many people, it has a very specific “profile.” It primarily affects women of childbearing age, often appearing several months to a few years after pregnancy or breastfeeding [7][8].

The exact cause of IGM is still being studied, but researchers believe it is a combination of factors:

  • Immune-Mediated Response: Your body’s immune system may be overreacting to proteins or secretions within the breast tissue [8].
  • Bacterial Factors: A specific type of bacteria called Corynebacterium is sometimes found in a subtype of this condition, though it is not a traditional “infection” like a standard breast abscess [9][10].
  • Systemic Connections: Some patients also experience symptoms outside the breast, such as erythema nodosum (tender, red bumps on the shins) or joint pain, which further suggests an immune system component [11][12].

Three Stabilizing Facts

If you are feeling overwhelmed, hold onto these core truths:

  1. It is NOT Cancer: IGM is a benign inflammatory condition [1]. While it requires careful management, it does not turn into cancer and does not increase your risk of developing breast cancer in the future [13].
  2. It is Treatable: There are many ways to manage IGM, ranging from “watchful waiting” (observation) to medications like corticosteroids or immune-modifying drugs [14][15].
  3. It Can Resolve: IGM is often a “self-limiting” condition, meaning that for many patients, it can eventually resolve on its own or with medical help without needing major surgery [13][16]. If observing without medication, it may take several months to a year for symptoms to fully resolve [16].

The Diagnostic “Odyssey”

The path to an IGM diagnosis is often called a “diagnostic odyssey” because it can take a long time and involve many tests [1]. It is normal to feel exhausted, anxious, or even traumatized by the initial suspicion of cancer. This condition significantly affects quality of life, not just because of the physical pain, but because of the emotional toll of the uncertainty [7]. Recognizing that your fear was a valid response to a confusing clinical picture is an important step in your healing process.

Return to Home

Common questions in this guide

Is Idiopathic Granulomatous Mastitis a type of breast cancer?
No, IGM is a benign, non-cancerous inflammatory condition. While it can look and feel exactly like breast cancer during physical exams and imaging tests, it does not turn into cancer and does not increase your future breast cancer risk.
Why is a biopsy needed to diagnose IGM?
IGM frequently mimics breast cancer on mammograms, ultrasounds, and MRIs by presenting with irregular shapes or increased blood flow. A core needle biopsy is the only definitive way to rule out cancer and confirm that the mass is actually inflammation.
Will I need major surgery to treat Idiopathic Granulomatous Mastitis?
Not necessarily. IGM is often self-limiting and can resolve on its own over several months to a year. Treatment usually ranges from watchful waiting to medications like corticosteroids, helping many patients avoid major surgery entirely.
What causes Idiopathic Granulomatous Mastitis?
The exact cause is still being studied, but researchers believe it involves an overactive immune response in the breast tissue. It frequently affects women of childbearing age after pregnancy, and some cases are linked to a specific bacteria called Corynebacterium.
Can IGM cause symptoms outside of the breast?
Some patients with IGM experience systemic symptoms related to an immune system response. This can include joint pain or tender, red bumps on the shins known as erythema nodosum.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my biopsy, can you explain exactly how IGM was confirmed and cancer was ruled out?
  2. 2.What is the standard approach to treatment in this clinic: observation, medication, or a combination?
  3. 3.Are you working with a multidisciplinary team (like a rheumatologist or infectious disease specialist) for my care?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Idiopathic granulomatous mastitis: case series and clinical review.

    Nguyen MH, Molland JG, Kennedy S, et al.

    Internal medicine journal 2021; (51(11)):1791-1797 doi:10.1111/imj.15112.

    PMID: 34713960
  2. 2

    Assertive clinical practice in managing patients with idiopathic granulomatous mastitis: Review of literature.

    Alsaleh N

    Annals of medicine and surgery (2012) 2021; (70()):102792 doi:10.1016/j.amsu.2021.102792.

    PMID: 34691410
  3. 3

    Cystic neutrophilic granulomatous mastitis: Focus on preoperative cytology and intraoperative consultation.

    Huang HY, Chuang CH, Lin CH

    The Kaohsiung journal of medical sciences 2022; (38(2)):176-177 doi:10.1002/kjm2.12460.

    PMID: 34595816
  4. 4

    Magnetic resonance imaging findings for inflammatory mastitis of unknown etiology.

    Macedo M, Ganau S, Úbeda B, et al.

    Radiologia 2024; (66(5)):410-418 doi:10.1016/j.rxeng.2023.02.006.

    PMID: 39426810
  5. 5

    Idiopathic granulomatous mastitis: magnetic resonance imaging findings with diffusion MRI.

    Aslan H, Pourbagher A, Colakoglu T

    Acta radiologica (Stockholm, Sweden : 1987) 2016; (57(7)):796-801 doi:10.1177/0284185115609804.

    PMID: 26508792
  6. 6

    A successful case of etanercept used for idiopathic granulomatous mastitis.

    Wang ST, Lin JC, Li CF, Lee YH

    The breast journal 2019; (25(2)):343-345 doi:10.1111/tbj.13219.

    PMID: 30790374
  7. 7

    Idiopathic granulomatous mastitis.

    Ivanička Vincent, Kaščák Peter

    Ceska gynekologie 2022; (87(5)):334-337 doi:10.48095/cccg2022334.

    PMID: 36316214
  8. 8

    Breastfeeding and secretory factors in idiopathic granulomatous mastitis: Unveiling etiological insights.

    Çetin K

    World journal of surgery 2025; (49(1)):15-23 doi:10.1002/wjs.12426.

    PMID: 39566914
  9. 9

    Cystic Neutrophilic Granulomatous Mastitis.

    Zahid QUA, Yaqoob N, Ferozuddin N, Hasan SH

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2022; (32(11)):1489-1491 doi:10.29271/jcpsp.2022.11.1489.

    PMID: 36377022
  10. 10

    Idiopathic granulomatous mastitis: a 5-year retrospective review of cases in a tertiary centre in Dublin, Ireland.

    Houlihan E, Ryan K, Mannion J, et al.

    Journal of clinical pathology 2024; (77(12)):835-841 doi:10.1136/jcp-2023-209028.

    PMID: 37699697
  11. 11

    Granulomatous mastitis, erythema nodosum, and arthritis syndrome: a narrative review.

    Li SG, Zhang J, Li J, et al.

    Frontiers in immunology 2025; (16()):1689710 doi:10.3389/fimmu.2025.1689710.

    PMID: 41438764
  12. 12

    [Idiopathic granulomatous mastitis associated with erythema nodosum].

    Jacquin-Porretaz C, Devalland C, Delapparent T, et al.

    Annales de dermatologie et de venereologie 2019; (146(8-9)):571-576 doi:10.1016/j.annder.2019.04.023.

    PMID: 31151772
  13. 13

    Re-evaluating if observation continues to be the best management of idiopathic granulomatous mastitis.

    Davis J, Cocco D, Matz S, et al.

    Surgery 2019; (166(6)):1176-1180 doi:10.1016/j.surg.2019.06.030.

    PMID: 31400951
  14. 14

    Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial.

    Shojaeian F, Haghighat S, Abbasvandi F, et al.

    Journal of the American College of Surgeons 2024; (238(6)):1153-1165 doi:10.1097/XCS.0000000000001046.

    PMID: 38372343
  15. 15

    Effectiveness of Methotrexate in Idiopathic Granulomatous Mastitis Treatment.

    Kehribar DY, Duran TI, Polat AK, Ozgen M

    The American journal of the medical sciences 2020; (360(5)):560-565 doi:10.1016/j.amjms.2020.05.029.

    PMID: 32635989
  16. 16

    Granulomatous lobular mastitis.

    Zhou F, Yu LX, Ma ZB, Yu ZG

    Chronic diseases and translational medicine 2016; (2(1)):17-21 doi:10.1016/j.cdtm.2016.02.004.

    PMID: 29063020

This page provides educational information about Idiopathic Granulomatous Mastitis and does not replace professional medical advice. Always discuss your biopsy results, diagnostic questions, and treatment options with your healthcare team.

Get notified when new evidence is published on Granulomatous mastitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.